C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2002
11/26/2002	US6485724 Immortalized human keratinocyte cell line
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2105984C Cloning and expression of renilla luciferase
11/26/2002	CA2100864C Method for delivering direct feed microorganisms to poultry in ovo
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2094277C Processing of yeast refuse and resulting product
11/26/2002	CA2050533C Phage defense rotation strategy
11/26/2002	CA2026703C Genetic manipulations with recombinant dna comprising sequences derived from rna virus
11/22/2002	WO2001090335A1 Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme
11/22/2002	CA2409961A1 New cyclodextrin glucanotransferase, method of manufacturing same, and method of manufacturing cyclodextrin employing this enzyme
11/22/2002	CA2383004A1 Non-anaphylactogenic ige vaccines
11/21/2002	WO2002093519A2 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002092857A1 Chemically assembled nano-scale circuit elements
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092829A1 Process for producing peptide
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092819A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
11/21/2002	WO2002092818A2 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
11/21/2002	WO2002092814A2 Screening method for attenuating or virulence defective microbial cells
11/21/2002	WO2002092811A1 Method of expressing long-chain prenyl diphosphate synthase
11/21/2002	WO2002092809A1 Novel hexenuronidase, gene coding for the same, and use of these
11/21/2002	WO2002092803A1 Phosphotriesterase from agrobacterium radiobacter p230
11/21/2002	WO2002092801A2 Methods and compositions for making emamectin
11/21/2002	WO2002092798A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/21/2002	WO2002092797A2 Alpha-amylase variant with altered properties
11/21/2002	WO2002092790A1 Kimchi lactic acid bacteria group hindering growth of helicobactor pyloli and high functional food protecting gastroenteric disorder therewith
11/21/2002	WO2002092789A1 Microorganism having ability to convert sterol into androst-4-ene-3,17-dione/androsta-1,4-diene-3,17-dione and preparation method and use thereof
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092765A2 Novel telomerase inhibitors and uses therefor
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092757A2 Enzyme over-producing transgenic microorganisms
11/21/2002	WO2002092741A2 0etergent compositions comprising bacillus subtilis pectate lyases
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092139A1 Methods for inactivating viruses
11/21/2002	WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002091824A2 Biological-chemical fungicide compositions and methods of use
11/21/2002	WO2002082432A8 Isolated genome of xyllela fastidiosa and uses thereof
11/21/2002	WO2002072845A3 Salmonella promoter for heterologous gene expression
11/21/2002	WO2002064624A3 Improved method for production of secreted proteins in fungi
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	WO2002046381A3 Method for the prevention or reduction of haze in beverages
11/21/2002	WO2002046152A3 Coniosetin and derivatives thereof, method for producing the same and use thereof
11/21/2002	WO2002042418A9 3-hydroxypropionic acid and other organic compounds
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001094383A3 Mutated furin polypeptides having improved characteristics
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders
11/21/2002	US20020173625 Hybrid polypeptide for use in the treatment and prevention of allergic disorders
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173463 Isolated nucleic acids; and antibodies
11/21/2002	US20020173462 Fibrinogen binding protein
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002	US20020173459 Isolated peptide; antibodies; genetic engineering
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173035 Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
11/21/2002	US20020173024 Nucleotide sequences coding polypeptide for use in the prevention of freezing damage to tissue during surgery associated with freezing tumors
11/21/2002	US20020173019 Enzymes for biopolymer production
11/21/2002	US20020173013 Nucleotide sequences coding polypeptide for use in the generation of S-N-benzylazetidine-2-carboxylic acid
11/21/2002	US20020173011 Generating amino acids for use in pharmocology, feeds and flavoring; obtain escherichia, incubate in nutrient broth, propagate, ferment and recover amino acids
11/21/2002	US20020173010 Process for preparation of D-pantothenic acid and/or salts thereof
11/21/2002	US20020173008 Recombinant polyketide synthase genes
11/21/2002	US20020173003 Directed evolution of microorganisms
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172997 Replication of preefrential nucleotide sequences; obtain nucleotide sequences, insert into vector, incubate with recombinase, recover vector, amplify nucleotide sequences
11/21/2002	US20020172985 Cassette for expressing a Toxoplasma gondii P30 protein
11/21/2002	US20020172976 P. gingivalis polynucleotides and uses thereof
11/21/2002	US20020172966 Detecting mutation in nucleotide sequences; obtain nucleotide sequences, join to oligomers, transform cells, detect mutations
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172951 Determnine the concentration of hysteresis proteins in sample; obtain protein sample, freeze, heat, monitor ice crystal grain adjustment, detect hysteresis proteins in solution
11/21/2002	US20020172944 Protein activity screening of clones having dna from uncultivated microorganisms
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172684 Useful in therapy, diagnosis, and prophylaxis of tuberculosis; vaccines
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	CA2447485A1 Chemically assembled nano-scale circuit elements
11/21/2002	CA2447139A1 Specific binding proteins and uses thereof
11/21/2002	CA2447114A1 Human antipneumococcal antibodies from non-human animals
11/21/2002	CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	CA2447041A1 Biological-chemical fungicide compositions and methods of use
11/21/2002	CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002	CA2446867A1 Global analysis of protein activities using proteome chips
11/21/2002	CA2446180A1 Cytokine polypeptides
11/21/2002	CA2446130A1 Methods and compositions for making emamectin
11/21/2002	CA2446113A1 Methods for inactivating viruses
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2444977A1 Method of expressing long-chain prenyl diphosphate synthase
11/21/2002	CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/20/2002	EP1258526A1 Process for preparing a sourdough with yeast and homo- and heterofermentative Lactobacilli

1 ... 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 ... 1489